|
FAM116A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.62481139653892E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.305600E-02 |
| Stage1-vs-Stage3 |
1.032210E-01 |
| Stage1-vs-Stage4 |
4.38140000003084E-06 |
| Stage2-vs-Stage3 |
5.001100E-03 |
| Stage2-vs-Stage4 |
1.7716000000334E-06 |
| Stage3-vs-Stage4 |
1.590370E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.48540077407711E-11 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
4.888800E-01 |
| Caucasian-vs-Asian |
5.533000E-01 |
| AfricanAmerican-vs-Asian |
3.640000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.119000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.14349999999786E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.776800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.357600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.683400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.589000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.723200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.825400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.34010000160967E-08 |
| Classical-VS-Follicular |
3.60500000000652E-05 |
| Classical-VS-Other |
4.791800E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
2.29627428183221E-12 |
| Tall-VS-Other |
8.870500E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
5.618300E-02 |
| Follicular-VS-Normal |
2.1094237467878E-15 |
| Other-VS-Normal |
1.04230000186334E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62436730732907E-12 |
| N0-vs-N1 |
2.738200E-03 |
|
|
